In the development of obesity pathology, weight loss has been shown to effectively lower CCL2 levels, thereby alleviating inflammation and reducing the risk of related conditions, such as macrophage activation, hepatocellular carcinoma, rheumatoid arthritis, and multiple myeloma [10,86]. This evidence concerns the gene CCL2 and obesity due to melanocortin 4 receptor deficiency.